Generic placeholder image

Current Drug Discovery Technologies

Author(s): Mojgan Azadpour, Mohammad Morad Farajollahi, Ali Mohammad Varzi, Pejman Hashemzadeh, Hossein Mahmoudvand and Mitra Barati*

DOI: 10.2174/1570163817666200827111127

DownloadDownload PDF Flyer Cite As
Extraction, Chemical Composition, Antioxidant Property, and In-vitro Anticancer Activity of Silymarin from Silybum marianum on Kb and A549 Cell Lines

Page: [511 - 517] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Introduction: This study aimed to evaluate the antioxidant property of Silymarin (SM) extracted from the seed of Silybum marianum and its anticancer activity on KB and A549 cell lines following 24, 48, and 72 h of treatment.

Methods: Ten grams of powdered S. marianum seeds were defatted using n-hexane for 6 hours and then extracted by methanol. The Silymarin extracted of extraction components. The extracted components of Silymarin were measured by spectrophotometric assay and HPLC analysis. 2, 2- diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, phenol content, total flavonoid content, and total antioxidant capacity were measured to detect the antioxidant properties of SM. The anticancer activity of the SM on cell lines evaluated by MTT.

Results: In HPLC analysis, more than 50% of the peaks were related to silybin A and B. SM was reduced DPPH (the stable free radical) with a 50% inhibitory concentration (IC50) of 6.56 μg/ ml in comparison with butylated hydroxyl toluene (BHT), which indicated an IC50 of ~3.9 μg/ ml. The cytotoxicity effect of SM on the cell lines was studied by MTT assay. The cytotoxicity effect of the extracted Silymarin on KB and A549 cell lines was observed up to 80 and 70% at 156 and 78 μg/ml, respectively. The IC50 value of the extracted SM on KB and A549 cell lines after 24 hours of treatment was seen at 555 and 511 μg/ml, respectively.

Conclusion: Due to the good antioxidant and anticancer properties of the isolated Silymarin, its use as an anticancer drug is suggested.

Keywords: Cytotoxicity, MTT assay, KB cell line, A549 cell line, Silymarin (SM), silybum marianum.

Graphical Abstract

[1]
Yadav B, Bajaj A, Saxena M, Saxena A. In vitro anticancer activity of the root, stem and leaves of Withania somnifera against various human cancer cell lines. Indian journal of pharmaceutical sciences 2010; 72(5): 659.
[2]
Florea A-M, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011; 3(1): 1351-71.
[3]
Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chemico-biological interactions 2011; 190(1): 9-15.
[4]
Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integrative cancer thera 2007; 6(2): 110-9.
[5]
Sayyah M, Boostani H, Pakseresht S, Malayeri A. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive− Compulsive Disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010; 34(2): 362-5.
[6]
Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001; 15(7): 465-89.
[7]
Wagner H, Horhamer L, Munster R. Structure of a new flavonoid from the Silybum marianum fruits. Naturwissenschaften 1965; 52: 305.
[8]
Elwekeel A, Elfishawy A, AbouZid S. Silymarin content in Silybum marianum fruits at different maturity stages. Journal of Medicinal Plants Research 2013; 7(23): 1665-9.
[9]
Fraschini F, Demartini G, Esposti D. Pharmacology of silymarin. Clinical drug investigation 2002; 22(1): 51-65.
[10]
Křen V, Walterová D. Silybin and silymarin-new effects and applications. Biomed papers 2005; 149(1): 29-41.
[11]
Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DYW. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-κB signaling, and HCV infection by standardized silymarin. Gastroenterology 2007; 132(5): 1925-36.
[12]
Ahmed–Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, Brillet R, et al. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Gastroenterology 2010; 138(3): 1112-22.
[13]
Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, et al. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology 2010; 138(2): 671-681. e2.
[14]
Lovelace ES, Wagoner J, MacDonald J, Bammler T, Bruckner J, Brownell J, et al. Silymarin suppresses cellular inflammation by inducing reparative stress signaling. Journal of natural products 2015; 78(8): 1990-2000.
[15]
Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. International immunopharmacology 2017; 50: 194-201.
[16]
Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. The Prostate 2002; 53(3): 211-7.
[17]
Mokhtari MJ, Motamed N, Shokrgozar MA. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC‐3) cell line. Cell biology international 2008; 32(8): 888-92.
[18]
Shokrpour M, Moghaddam M, Mohammadi SA, Ziai SA, Javanshir A. Genetic properties of milk thistle ecotypes from Iran for morphological and flavonolignans characters. Pakistan journal of biological sciences. PJBS 2007; 10(19): 3266-71.
[19]
Mirzadeh-Ahari E, Khosrowshohli M, Movafegi A. Investigating of karyological variation on some ecotypes of medicinal plant, Silybum marianum (L.) Gaertn., in Iran. New Cellular and Molecular Biotechnology Journal 2014; 4(13): 57-64.
[20]
AbouZid S. Yield improvement strategies for the production of secondary metabolites in plant tissue culture: silymarin from Silybum marianum tissue culture. Natural product research 2014; 28(23): 2102-10.
[21]
Cianchino V, Jofre M, Peralta C, Favier L, Ortega C, Cifuente D. A NEW DESIGN OF SILYBUM MARIANUM TABLETS BY DIRECT COMPRESSION 2019.
[22]
Chen Y, Wang M, Rosen RT, Ho C-T. 2, 2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum Thunb. Journal of agricultural and food chemistry 1999; 47(6): 2226-8.
[23]
Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. American journal of Enology and Viticulture 1965; 16(3): 144-58.
[24]
Ordonez A, Gomez J, Vattuone M. Antioxidant activities of Sechium edule (Jacq.) Swartz extracts. Food chemistry 2006; 97(3): 452-8.
[25]
Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Analytical biochemistry 1999; 269(2): 337-41.
[26]
Shen Y, Zhao H, Wang Z, Guan W, Kang X, Tai X, et al. Silibinin declines blue light-induced apoptosis and inflammation through MEK/ERK/CREB of retinal ganglion cells. Artificial cells nanomedicine and biotechnology 2019; 47(1): 4059-65.
[27]
Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. “Silymarin”, a promising pharmacological agent for treatment of diseases. Iranian journal of basic medical sciences 2011; 14(4): 308.
[28]
CİHAN B. YARAT A, AKBAY TT, ŞENER G. Investigation of the effect of silymarin on the liver in experimental sepsis. Marmara Pharmaceutical Journal 2015; 19(1): 52-9.
[29]
Guenné S, Balmus I-M, Ciobica A. Asteraceae family plants in most of the neuropsychiat disorders treatment
[30]
Rastegar H, Ashtiani HA, Anjarani S, Bokaee S, Khaki A, Javadi L. The role of milk thistle extract in breast carcinoma cell line (MCF-7) apoptosis with doxorubicin. Acta Medica Iranica 2013; 591-8.
[31]
Yang S-H, Lin J-K, Chen W-S, Chiu J-H. Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. Journal of Surgical Research 2003; 113(1): 133-8.
[32]
Ge Y, Zhang Y, Chen Y, Li Q, Chen J, Dong Y, et al. Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells. International journal of molecular sciences 2011; 12(8): 4861-71.
[33]
Sherman B, Hernandez AM, Alhado M, Menge L, Price RS. Silibinin Differentially Decreases the Aggressive Cancer Phenotype in an In Vitro Model of Obesity and Prostate Cancer. Nutrition and cancer 2019; 1-10.
[34]
Tag HM, Bargougui A, Alshayyal SG, Kamal A, Tantawy HM, El-Naggar MS. Chemopreventive Efficacy of Punica granatum and Silybum marianum Extracts on Chemically-induced Hepatocellular Carcinoma in Rats. Asian Journal of Applied Sciences (ISSN:2321–0893) 2019; 7(02)
[35]
Saleh IA, Vinatoru M, Mason TJ, Abdel-Azim NS, Shams KA, Aboutabl E, et al. Extraction of silymarin from milk thistle (Silybum marianum) seeds–a comparison of conventional and microwave-assisted extraction methods. Journal of Microwave Power and Electromagnetic Energy 2017; 51(2): 124-33.
[36]
Lucini L, Kane D, Pellizzoni M, Ferrari A, Trevisi E, Ruzickova G, et al. Phenolic profile and in vitro antioxidant power of different milk thistle [Silybum marianum (L.) Gaertn.] cultivars. Industrial Crops and Products 2016; 83: 11-6.
[37]
Salem N, Dhifi W, Graya A, Mnafeg F, Gharbi S, Khammassi S, et al. Antioxidant activity of Silybum marianum and Ajuga iva natural dyes. International Journal of Control. Energy and Electrical Engineering 2016; 3(2): 6-12.
[38]
Karahan F, Kulak M, Urlu E, Gözüacik HG, Böyümez T, Şekeroğlu N, et al. Total phenolic content, ferric reducing and DPPH scavenging activity of Arum dioscoridis. Natural product research 2015; 29(17): 1678-83.
[39]
Saller R, Melzer J, Reichling J, Brignoli R, Meier R. An updated systematic review of the pharmacology of silymarin. Complementary Medicine Research 2007; 14(2): 70-80.
[40]
Gazak R, Walterova D, Kren V. Silybin and silymarin-new and emerging applications in medicine. Current medicinal chemistry 2007; 14(3): 315-38.
[41]
Li L-H, Wu L-J, Jiang Y-Y, Tashiro S-I, Onodera S, Uchiumi F, et al. Silymarin enhanced cytotoxic effect of anti-Fas agonistic antibody CH11 on A375-S2 cells. Journal of Asian natural products research 2007; 9(7): 593-602.
[42]
Snima K, Arunkumar P, Jayakumar R, Lakshmanan V-K. Silymarin encapsulated poly (D, L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapy. Journal of biomedical nanotechnology 2014; 10(4): 559-70.
[43]
Zi X, Grasso AW, Kung H-J, Agarwal R. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer research 1998; 58(9): 1920-9.
[44]
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. British journal of cancer 1972; 26(4): 239.
[45]
Abenavoli L, Aviello G, Capasso R, Milic N, Capasso F. Milk thistle for treatment of nonalcoholic fatty liver disease 2011.